»

Türkçe - English

PDF Version | Add to Favorites | Goto Homepage

The Conservative Management of Placenta Previa Percreta: Presentation of Two Cases
Perinatal Journal 2011; 19(3):145 - 148

Case Report

e-Address: http://www.perinataljournal.com/20110193009
The Conservative Management of Placenta Previa Percreta: Presentation of Two Cases
Zehra Kurdoğlu, Ertan Adalı, Gülçin Ay
Yüzüncü Yıl Üniversitesi Tıp Fakültesi, Kadın Hastalıkları ve Doğum AD., VAN, TR
 

Objective : In this case report, we aimed to discuss two cases with placenta previa percreta who were managed and treated successfully by being applied methotrexate in the postoperative period.

Case(s) : Both of the two cases who were undergone operation immediately due to previous cesarean deliveries applied to our clinic as onset of labors. The placentas were left in uterus due to fertility desires of women who were diagnosed placenta percreta in surgery. The patients who were managed with conservative therapy were followed up by serum human chorionic gonadotrophin (hCG) levels, ultrasonography and magnetic resonance imaging. After therapy, decrease of serum hCG levels, vascularisation and size of the placenta were observed.

Conclusion : Placenta percreta which cause serious morbidity and mortality is one of the most important complications of pregnancy. To decrease morbidity and preserve fertility, conservative treatment may be thought firstly.

Keywords : Placenta previa percreta, conservative treatment, methotrexate

Plasenta Previa Perkretanın Konservatif Yönetimi: İki Olgu Sunumu

Amaç : Bu makalede, sezaryen ile fetüs doğurtulduktan sonra plasentaları yerinde bırakılan ve postoperatif dönemde metotreksat uygulanarak başarılı bir şekilde takip ve tedavileri yapılan plasenta previa perkretalı olguların tartışılması amaçlandı.

Olgu(lar) : Daha önceki doğumlarının da sezaryenle olması nedeniyle acil şartlarda operasyona alınan her 2 olgu da doğum eyleminin başlaması nedeniyle kliniğimize başvurdu. İntraoperatif plasenta perkreata tespit edilen bu hastalarda plasentanın çıkarılması, morbiditeyi artırabileceğinden plasentalar uterin kavite içinde bırakıldı. Konservatif metotreksat tedavisi ile takibe alınan hastalar, postoperatif serum beta human koryonik gonodotropin (hCG) düzeyleri, ultrasonografi ve manyetik rezonans görüntüleme ile takip edildi. Tedavi ile serum betahCG düzeylerinde, plasentanın boyut ve vaskülarizasyonunda belirgin azalma izlendi.

Sonuç : Plasenta perkreta, ciddi morbidite ve mortaliteye neden olan gebeliğin oldukça önemli komplikasyonlarından biridir. Morbiditeyi azaltmak ve fertiliteyi korumak amacıyla konservatif tedavi öncelikle düşünülebilir.

Anahtar Sözcükler : Plasenta previa perkreata, konservatif tedavi, metotreksat


 
Introduction
Case(s)
Discussion
Conclusion
Literature
1) Iyasu S, Saftlas AK, Rowley DL, Koonin LM, Lawson HW, Atrash HK.The epidemiology of placenta previa in the United States, 1979 through 1987.Am J Obstet Gynecol 1993; 168:1424-9..
2) Chan BCP, Lam HSW, Yuen JHF, Lam TPW, Tso WK, Pun TC et al.Conservative management of placenta previa with accreta.Hong Kong Med J 2008;14:479-84.
3) Comstock CH.Antenatal diagnsis of placenta accreta: a review.Ultrasound Obstet Gynecol 2005;26:89-96.
4) Breen JL, Neubecker R, Gregori CA, Franklin JE.Placenta Accreta, Increta and Percreta: A Survey of 40 Cases.Obstetrics & Gynecolgy 1977;49:43-47.
5) Henrich W, Fuchs I, Ehrenstein T, Kjos S, Schmıder A, Dudenhausen JW.Antenatal diagnosis of placenta percreta with planned in situ retention and methotrexate therapy in a woman infected with HIV.Ultrasound Obstet Gynecol 2002; 20: 90-93.
6) Levine D, Hulka CA, Ludmir J, Li W, Edelman RR.Placenta accreta: evaluation with color Doppler US, power Doppler US, and MR imaging.Radiology 1997;205(3):773-6.
7) Rao AP, Bojahr H, Beski S, MacCallum PK, Renfrew I.7.     Rao AP, Bojahr H, Beski S, MacCallum PK, Renfrew I.J Obstet Gynaecol 2010;30(7):687-9.
8) Doumouchtsis SK, Arulkumaran S.The morbidly adherent placenta: an overview of management options.Acta Obstet Gynecol Scand 2010; 89(9):1126-33.
9) Teo TH, Law YM, Tay KH, Tan BS, Cheah FK.Use of magnetic resonance imaging in evaluation of placental invasion.Clin Radiol 2009;64(5):511-6.
10) Elsayes KM, Trout AT, Friedkin AM, Liu PS, Bude RO, Platt JF, Menias CO.Imaging of the placenta: a multimodality pictorial review.Radiogaraphics 2009; 29(5):1371-91.
11) Silver LE, Hobel CJ, Lagasse L, Luttrull JW, Platt LD.Placenta previa percreta with bladder involvement: new considerations and review of the literature.Ultrasound Obstet Gynecol 1997;9:131-8.
12) Yumru E, Bozkurt M, Özdemir F, Ayanoğlu T, Tuzlalı P.Plasenta Perkreta: Olgu Sunumu.Perinatoloji Dergisi 2005; 13(1): 44-48.
13) Heiskanen N, Kroger J, Kainulainen S, Heinonen S.Placenta percreta: methotrexate treatment and MRI findings.Am J Perinatol 2008;25(2):91-92.
14) Mussalli GM, Shah J, Berck DJ, Elimian A, Tejani N, Manning FA.Placenta accreta and methotrexate therapy: three case reports.J Perinatol 2000;20(5):331–334.
15) Sonin A.Nonoperative treatment of placenta percreta:value of MR imaging.Am J Roentgenol 2001;177:1301–1303.
 
Article Attachments
Info File Name File Size File Type Order
[ Info ] resim_1.jpg 103,53Kb Color Figure 1
[ Info ] resim_2.jpg 483,57Kb Color Figure 2